Product Overview
Description
CEP55 protein is a recombinant human CEP55 produced in E. coli Gln189-Lys464 with N-terminal His Tag with His, N-Terminal tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method).
Nature
Recombinant Protein
Endotoxin Level
< 1.0 Eu/µg (determined by LAL method)
Sequence
MSSRSTKDLIKSKWGSKPSNSKSETTLEKLKGEIAHLKTSVDEITSGKGKLTDKERHRLLEKIRVLEAEKEKNAYQLTEKDKEIQRLRDQLKARYSTTTLLEQLEETTREGERREQVLKALSEEKDVLKQQLSAATSRIAELESKTNTLRLSQTVAPNCFNSSINNIHEMEIQLKDALEKNQQWLVYDQQREVYVKGLLAKIFELEKKTETAAHSLPQQTKKPESEGYLQEEKQKCYNDLLASAKKDLEVERQTITQLSFELSEFRRKYEETQKEVHNLNQLLYSQRRADVQHLEDDRHKTEKIQKLREENDIARGKLEEEKKRSEELLSQVQFLYTSLLKQQEEQTRVALLEQQMQACTLDFENEKLDRQHVQHQLHVILKELRKARNQITQLESLKQLHEFAITEPLVTFQGETENREKVAASPKSPTAALNESLVECPKCNIQYPATEHRDLLVHVEYCSK
Predicted Molecular Weight
36.2kDa
Target Information
Alternative Names
CEP55; Cancer/testis antigen 111; Centrosomal protein of 55 kDa; C10orf3; CT111; Centrosomal protein 55kDa; URCC6; Up-regulated in colon cancer 6
Protein Function
Plays a role in mitotic exit and cytokinesis. Recruits PDCD6IP and TSG101 to midbody during cytokinesis. Required for successful completion of cytokinesis. Not required for microtubule nucleation. Plays a role in the development of the brain and kidney.
Involvement in Disease
Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly (MARCH): An autosomal recessive, congenital disease characterized by severe hydranencephaly with multinucleated neurons, renal aplasia or dysplasia, and hypoplastic kidneys. Hydranencephaly is an anomaly leading to replacement of the cerebral hemispheres with a fluid-filled cyst. MARCH results in death in utero or in the perinatal period. The disease is caused by variants affecting the gene represented in this entry.
Shipping & Handling
Constituents
Lyophilized from PBS, pH7.4, 0.01% SKL, 1 mM DTT, 5% Trehalose, Proclin300.
Shipping
Shipped on dry ice.
Storage
Store at -80 °C for up to 1 year.
